| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ankyrin repeat and fibronectin type III domain containing 1 | 0.890 | 0.154 | 2.1E-10 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2011 | 2011 | ||||||||
|
PTPRF interacting protein alpha 2 | 0.861 | 0.154 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
GRIP and coiled-coil domain containing 1 | 0.769 | 0.192 | 1.4E-06 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
regulator of G protein signaling 20 | 0.760 | 0.269 | 6.4E-05 |
|
disease | 0.310 | None | < 0.001 | 1 | 0 | 2012 | 2012 | ||||||||
|
apolipoprotein L2 | 0.722 | 0.308 | 7.3E-03 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
gulonolactone (L-) oxidase, pseudogene | 0.805 | 0.308 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||
|
cholinergic receptor muscarinic 5 | 0.769 | 0.346 | 4.0E-03 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
regulator of G protein signaling 17 | 0.716 | 0.346 | 0.27 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
Beta-adrenergic stimulation, response to | 0.711 | 0.346 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
allantoicase | 0.695 | 0.385 | 4.2E-16 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
beaded filament structural protein 2 | 0.686 | 0.385 | 3.2E-08 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
ankyrin repeat and kinase domain containing 1 | 0.604 | 0.462 | 7.4E-12 |
|
disease | 0.310 | None | < 0.001 | 1 | 1 | 2015 | 2015 | ||||||||
|
solute carrier family 17 member 6 | 0.678 | 0.500 | 0.16 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
cyclin dependent kinase 15 | 0.663 | 0.500 | 2.2E-17 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
5-hydroxytryptamine receptor 2B | 0.647 | 0.538 | 2.7E-10 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
calcium/calmodulin dependent protein kinase II beta | 0.626 | 0.538 | 0.74 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
dopamine receptor D4 | 0.517 | 0.577 | 9.3E-09 |
|
disease | 0.330 | None | 1.000 | 4 | 0 | 2012 | 2013 | ||||||||
|
prodynorphin | 0.535 | 0.577 | 1.7E-04 |
|
disease | 0.310 | None | 1.000 | 2 | 1 | 2001 | 2018 | ||||||||
|
transient erythroblastopenia of childhood | 0.659 | 0.577 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | |||||||||
|
cyclin dependent kinase 16 | 0.636 | 0.577 | 0.99 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
EBP like | 0.615 | 0.577 | 7.8E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
tousled like kinase 1 | 0.641 | 0.577 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
farnesyl-diphosphate farnesyltransferase 1 | 0.621 | 0.615 | 4.1E-15 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
neuropeptide S | 0.619 | 0.615 | 1.4E-04 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
sarcoglycan gamma | 0.621 | 0.615 | 4.8E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 |